Which changes can a pharmacist make on a C2 prescription?

In the context of a C2 prescription, specific regulations govern what changes a pharmacist can make while ensuring patient safety and maintaining compliance with legal standards. The correct response highlights the ability of pharmacists to make changes to the dosage form, strength, and quantity after consulting with the prescribing physician. This is permissible because such modifications can be clinically necessary and can have significant positive outcomes for the patient’s health when coordinated with the prescribing provider.

The change in dosage form, strength, or quantity can be essential in managing a patient’s treatment plan effectively, and it ensures that the medication meets their therapeutic needs. However, this must be done with the consultation of the prescriber to maintain continuity of care and to ensure the changes are appropriate.

Changes to the patient's name or the issue date pose significant legal and ethical concerns. A change to the patient's name could lead to issues such as medication errors, identity theft, and legal liability. Similarly, altering the issue date without proper authority could affect the prescription's validity, tracking, and adherence to controlled substance regulations. Thus, these actions are not permitted.

The option encompassing all changes is therefore incorrect, as the capabilities of a pharmacist in modifying a prescription are limited to specific conditions that prioritize patient safety and regulatory compliance.